Free shipping on orders over $99Ships to the US and Canada New: dosage, calculator and shelf life for all 46 peptides →

Kisspeptin-10: What It Is

Kisspeptin-10: What It Is

Most peptides that get discussed in a research context act somewhere in the middle of a hormone pathway. Kisspeptin-10 sits at the top of one. It is the signal that tells the hypothalamus to start the entire reproductive hormone cascade, which is why it went from an obscure gene product to one of the more heavily studied peptides in endocrinology in about twenty years.

Here is what it is, how it was found, and what the published research covers.

What kisspeptin-10 is

Kisspeptin-10 (KP-10) is a ten-amino-acid fragment of a larger peptide encoded by the KISS1 gene. The full-length product, kisspeptin-54, is also called metastin. KP-10 corresponds to residues 112–121 of that parent peptide — the C-terminal end.

That fragment matters because it is the shortest piece that still activates the receptor at full potency. Everything upstream of those ten amino acids can be removed without losing binding activity, which makes KP-10 the standard form used in most laboratory work.

The receptor it binds is KISS1R, a G-protein-coupled receptor that was known as GPR54 before its ligand was identified.

How it was discovered

The KISS1 gene was originally identified in the mid-1990s as a metastasis suppressor in melanoma — hence “metastin.” Its role in reproduction was found by accident almost a decade later.

In 2003, two research groups independently reported that people with loss-of-function mutations in GPR54 presented with hypogonadotropic hypogonadism: they did not go through puberty normally, and their gonadotropin levels stayed low. Mice engineered without the receptor showed the same pattern.

That was the finding that reframed the whole field. A receptor nobody had connected to reproduction turned out to be a required gate for it. Work since then has been about mapping what sits on either side of that gate.

The mechanism

The pathway runs in a straight line, which is unusual and part of why it is studied so heavily:

Kisspeptin neurons in the hypothalamus — concentrated in the arcuate nucleus and the anteroventral periventricular nucleus — release kisspeptin. It binds KISS1R on GnRH neurons. Those neurons release gonadotropin-releasing hormone into the portal circulation. GnRH reaches the anterior pituitary and triggers release of luteinizing hormone and follicle-stimulating hormone. LH and FSH act on the gonads, driving testosterone or estradiol production and gamete development.

Flow diagram of the kisspeptin pathway: kisspeptin neurons in the hypothalamus release kisspeptin-10, which binds KISS1R on GnRH neurons, triggering GnRH release, then LH and FSH from the anterior pituitary, then testosterone or estradiol from the gonads, with sex-steroid feedback returning to the kisspeptin neurons.
Kisspeptin-10 acts upstream of GnRH. Sex-steroid feedback returns to the kisspeptin neurons rather than to GnRH neurons directly, which is why this step integrates hormonal, metabolic and stress input for the entire axis.

Kisspeptin neurons are where the feedback lands, too. Sex steroids feed back onto these neurons rather than directly onto GnRH neurons, which is how the loop closes. That position — upstream of GnRH, downstream of steroid feedback — is what makes kisspeptin the integration point for the whole axis.

It is also where metabolic and stress signals enter. Leptin, nutritional state, and stress hormones all influence kisspeptin neuron activity, which is a working explanation for why reproductive function suppresses under low body fat or chronic stress.

Pulsatility and the half-life problem

Two properties dominate any experimental design involving KP-10.

The half-life is very short. Intravenous KP-10 clears from human plasma in roughly four minutes. Kisspeptin-54 lasts considerably longer — on the order of half an hour — which is why studies needing sustained exposure often use the longer form instead.

Continuous exposure stops working. Sustained receptor occupancy causes desensitization. Keep KISS1R stimulated without interruption and the downstream LH response falls off rather than staying elevated. The natural system is pulsatile for this reason, and experimental protocols that ignore it produce the opposite of the intended effect.

Together these mean the timing of administration in a study design matters as much as the amount. This is a peptide where a continuous-infusion protocol and a pulsed protocol give genuinely different results.

Two side-by-side line charts of LH response over time. Pulsed exposure shows repeated spikes returning to the same height; continuous exposure shows one spike decaying to a flat low line.
Pulsed versus continuous exposure. Because sustained occupancy desensitizes KISS1R, a continuous-infusion protocol and a pulsed protocol produce opposite outcomes from the same compound.

What the research covers

Kisspeptin has more human clinical literature behind it than most compounds in this category, largely from work at Imperial College London and a handful of other groups. The main threads:

Gonadotropin response. The best-characterised finding is straightforward — administering kisspeptin raises LH, and to a lesser degree FSH, in healthy adults of both sexes. This is the effect most other work is built on.

Hypothalamic amenorrhea. Because the condition involves suppressed GnRH pulsatility, kisspeptin has been studied as a way to probe whether the axis below the block is still functional.

Oocyte maturation triggers. Kisspeptin-54 has been trialled as an alternative to hCG for triggering final oocyte maturation in IVF. The interest is in reduced ovarian hyperstimulation syndrome risk, since the kisspeptin-driven LH surge is shorter and more physiological than an hCG trigger.

Brain processing studies. Functional MRI work has looked at kisspeptin’s effects on limbic activity during sexual and emotional processing tasks, which points at central actions beyond the pituitary.

None of this constitutes approval for any therapeutic use. Kisspeptin is not an approved drug in any jurisdiction, and everything above describes investigational research.

Handling and storage

Kisspeptin-10 arrives lyophilized. Handling follows the same rules as other lyophilized peptides, and the short half-life makes solution stability more relevant than usual:

  • Lyophilized: store at -20°C, away from UV light. Stable long-term in this state.
  • Reconstitution: bacteriostatic water, added slowly down the vial wall rather than directly onto the powder. Swirl, do not shake — agitation shears peptide bonds.
  • After reconstitution: 2–8°C, used within about 30 days.
  • Freeze-thaw cycles: avoid them. Aliquot instead if a solution needs to be kept longer.

If you are working out concentrations, our peptide dosage calculator converts milligrams to micrograms and gives you the syringe units, and the dosage reference charts cover the common reconstitution volumes.

In short

Kisspeptin-10 is interesting because of where it sits rather than what it does directly. It is the upstream gate on the reproductive axis, the point where metabolic and stress input reaches that axis, and one of the few peptides in this space with a substantial body of human clinical research behind it. The short half-life and desensitization behaviour make it demanding to work with, and both are well documented.

Our Kisspeptin-10 is HPLC and mass spectrometry tested to ≥99% purity, same as the rest of the catalogue.

All products are strictly for laboratory and research purposes only. Not for human or animal consumption. Nothing above is medical advice.

Peptides Power Andrew

Peptides Power Andrew

I’m Peptides Power Andrew, and I write the guides on PeptidesPower.com to help adults understand peptides in a clear, practical way. I focus on straightforward education around peptide basics, common goals people research (recovery, wellness, body composition), and the key questions that come up like reconstitution, storage, and general dosing frameworks without the hype. My aim is to make complex topics easier to follow so you can make more informed, responsible decisions.